Evidence map›Paper›PMID 30034591›Full record

ArticleACS medicinal chemistry letters2018

Novel Aminoquinoline Derivatives Significantly Reduce Parasite Load in

Jelena Konstantinović, Milica Videnović, Stefania Orsini, Katarina Bogojević, Sarah D'Alessandro, Diletta Scaccabarozzi, Nataša Terzić Jovanović, Luigi Gradoni, Nicoletta Basilico, Bogdan A Šolaja

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS medicinal chemistry letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Nongenotoxic 3-Nitroimidazo[1,2-ACS medicinal chemistry letters · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Jelena KonstantinovićUniversity of Belgrade, Faculty of Chemistry, Studentski trg 12-16, P.O. Box 51, 11158 Belgrade, Serbia.
Milica VidenovićUniversity of Belgrade, Faculty of Chemistry Innovative Centre, Studentski trg 12-16, 11158 Belgrade, Serbia.
Stefania OrsiniUnit of Vector-borne Diseases, Istituto Superiore di Sanità, Rome, Italy.
Katarina BogojevićUniversity of Belgrade, Faculty of Chemistry, Studentski trg 12-16, P.O. Box 51, 11158 Belgrade, Serbia.
Sarah D'AlessandroDipartimento di Scienze Biomediche, Chirurgiche e Odontoiatrichè, Università degli Studi di Milano, Milan, Italy.
Diletta ScaccabarozziDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy.
Nataša Terzić JovanovićUniversity of Belgrade, Institute of Chemistry, Technology, and Metallurgy, Njegoševa 12, 11000 Belgrade, Serbia.
Luigi GradoniUnit of Vector-borne Diseases, Istituto Superiore di Sanità, Rome, Italy.
Nicoletta BasilicoUniversity of Belgrade, Faculty of Chemistry, Studentski trg 12-16, P.O. Box 51, 11158 Belgrade, Serbia.
Bogdan A ŠolajaUniversity of Belgrade, Faculty of Chemistry, Studentski trg 12-16, P.O. Box 51, 11158 Belgrade, Serbia.
University of Belgrade · RSIstituto Superiore di Sanità · ITUniversity of Milan · ITSerbian Academy of Sciences and Arts · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this Letter, a detailed analysis of 30 4-aminoquinoline-based compounds with regard to their potential as antileishmanial drugs has been carried out. Ten compounds demonstrated IC

Identifiers

PMID30034591
PMCPMC6047044
OpenAlexW2800499925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.